The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
The global Natamycin market was valued at US$ 186 million in 2023 and is anticipated to reach US$ 288.6 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report aims to provide a comprehensive presentation of the global market for Natamycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.
Report Scope
The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natamycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natamycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Segment by Application
Food
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Natamycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
The global Natamycin market was valued at US$ 186 million in 2023 and is anticipated to reach US$ 288.6 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report aims to provide a comprehensive presentation of the global market for Natamycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natamycin.
Report Scope
The Natamycin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natamycin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natamycin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Segment by Application
Food
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Natamycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Natamycin Market Overview
1.1 Product Overview and Scope of Natamycin
1.2 Natamycin Segment by Type
1.2.1 Global Natamycin Market Value Comparison by Type (2024-2030)
1.2.2 Glucose-based
1.2.3 Lactose-based
1.2.4 Sodium chloride-based
1.3 Natamycin Segment by Application
1.3.1 Global Natamycin Market Value by Application: (2024-2030)
1.3.2 Food
1.3.3 Medical
1.3.4 Others
1.4 Global Natamycin Market Size Estimates and Forecasts
1.4.1 Global Natamycin Revenue 2019-2030
1.4.2 Global Natamycin Sales 2019-2030
1.4.3 Global Natamycin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Natamycin Market Competition by Manufacturers
2.1 Global Natamycin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Natamycin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Natamycin Average Price by Manufacturers (2019-2024)
2.4 Global Natamycin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Natamycin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Natamycin, Product Type & Application
2.7 Natamycin Market Competitive Situation and Trends
2.7.1 Natamycin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Natamycin Players Market Share by Revenue
2.7.3 Global Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Natamycin Retrospective Market Scenario by Region
3.1 Global Natamycin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Natamycin Global Natamycin Sales by Region: 2019-2030
3.2.1 Global Natamycin Sales by Region: 2019-2024
3.2.2 Global Natamycin Sales by Region: 2025-2030
3.3 Global Natamycin Global Natamycin Revenue by Region: 2019-2030
3.3.1 Global Natamycin Revenue by Region: 2019-2024
3.3.2 Global Natamycin Revenue by Region: 2025-2030
3.4 North America Natamycin Market Facts & Figures by Country
3.4.1 North America Natamycin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Natamycin Sales by Country (2019-2030)
3.4.3 North America Natamycin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Natamycin Market Facts & Figures by Country
3.5.1 Europe Natamycin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Natamycin Sales by Country (2019-2030)
3.5.3 Europe Natamycin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Natamycin Market Facts & Figures by Country
3.6.1 Asia Pacific Natamycin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Natamycin Sales by Country (2019-2030)
3.6.3 Asia Pacific Natamycin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Natamycin Market Facts & Figures by Country
3.7.1 Latin America Natamycin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Natamycin Sales by Country (2019-2030)
3.7.3 Latin America Natamycin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Natamycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Natamycin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Natamycin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Natamycin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Natamycin Sales by Type (2019-2030)
4.1.1 Global Natamycin Sales by Type (2019-2024)
4.1.2 Global Natamycin Sales by Type (2025-2030)
4.1.3 Global Natamycin Sales Market Share by Type (2019-2030)
4.2 Global Natamycin Revenue by Type (2019-2030)
4.2.1 Global Natamycin Revenue by Type (2019-2024)
4.2.2 Global Natamycin Revenue by Type (2025-2030)
4.2.3 Global Natamycin Revenue Market Share by Type (2019-2030)
4.3 Global Natamycin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Natamycin Sales by Application (2019-2030)
5.1.1 Global Natamycin Sales by Application (2019-2024)
5.1.2 Global Natamycin Sales by Application (2025-2030)
5.1.3 Global Natamycin Sales Market Share by Application (2019-2030)
5.2 Global Natamycin Revenue by Application (2019-2030)
5.2.1 Global Natamycin Revenue by Application (2019-2024)
5.2.2 Global Natamycin Revenue by Application (2025-2030)
5.2.3 Global Natamycin Revenue Market Share by Application (2019-2030)
5.3 Global Natamycin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Danisco
6.1.1 Danisco Corporation Information
6.1.2 Danisco Description and Business Overview
6.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Danisco Natamycin Product Portfolio
6.1.5 Danisco Recent Developments/Updates
6.2 DSM
6.2.1 DSM Corporation Information
6.2.2 DSM Description and Business Overview
6.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 DSM Natamycin Product Portfolio
6.2.5 DSM Recent Developments/Updates
6.3 VGP
6.3.1 VGP Corporation Information
6.3.2 VGP Description and Business Overview
6.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 VGP Natamycin Product Portfolio
6.3.5 VGP Recent Developments/Updates
6.4 Handary
6.4.1 Handary Corporation Information
6.4.2 Handary Description and Business Overview
6.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Handary Natamycin Product Portfolio
6.4.5 Handary Recent Developments/Updates
6.5 AMTECH BIOTECH
6.5.1 AMTECH BIOTECH Corporation Information
6.5.2 AMTECH BIOTECH Description and Business Overview
6.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AMTECH BIOTECH Natamycin Product Portfolio
6.5.5 AMTECH BIOTECH Recent Developments/Updates
6.6 Silver-Elephant
6.6.1 Silver-Elephant Corporation Information
6.6.2 Silver-Elephant Description and Business Overview
6.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Silver-Elephant Natamycin Product Portfolio
6.6.5 Silver-Elephant Recent Developments/Updates
6.7 Lanzhou Weiri
6.6.1 Lanzhou Weiri Corporation Information
6.6.2 Lanzhou Weiri Description and Business Overview
6.6.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Weiri Natamycin Product Portfolio
6.7.5 Lanzhou Weiri Recent Developments/Updates
6.8 Langfang Meihua
6.8.1 Langfang Meihua Corporation Information
6.8.2 Langfang Meihua Description and Business Overview
6.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Langfang Meihua Natamycin Product Portfolio
6.8.5 Langfang Meihua Recent Developments/Updates
6.9 Zhengzhou New Frey
6.9.1 Zhengzhou New Frey Corporation Information
6.9.2 Zhengzhou New Frey Description and Business Overview
6.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhengzhou New Frey Natamycin Product Portfolio
6.9.5 Zhengzhou New Frey Recent Developments/Updates
6.10 Chihon
6.10.1 Chihon Corporation Information
6.10.2 Chihon Description and Business Overview
6.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chihon Natamycin Product Portfolio
6.10.5 Chihon Recent Developments/Updates
6.11 Jiaozuo Joincare
6.11.1 Jiaozuo Joincare Corporation Information
6.11.2 Jiaozuo Joincare Natamycin Description and Business Overview
6.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiaozuo Joincare Natamycin Product Portfolio
6.11.5 Jiaozuo Joincare Recent Developments/Updates
6.12 Beijing Oriental Rada
6.12.1 Beijing Oriental Rada Corporation Information
6.12.2 Beijing Oriental Rada Natamycin Description and Business Overview
6.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Oriental Rada Natamycin Product Portfolio
6.12.5 Beijing Oriental Rada Recent Developments/Updates
6.13 Pucheng Lifecome
6.13.1 Pucheng Lifecome Corporation Information
6.13.2 Pucheng Lifecome Natamycin Description and Business Overview
6.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Pucheng Lifecome Natamycin Product Portfolio
6.13.5 Pucheng Lifecome Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Natamycin Industry Chain Analysis
7.2 Natamycin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Natamycin Production Mode & Process
7.4 Natamycin Sales and Marketing
7.4.1 Natamycin Sales Channels
7.4.2 Natamycin Distributors
7.5 Natamycin Customers
8 Natamycin Market Dynamics
8.1 Natamycin Industry Trends
8.2 Natamycin Market Drivers
8.3 Natamycin Market Challenges
8.4 Natamycin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
